Saudi Chemical 9M 2024 profit climbs to SAR 237.2M; Q3 at SAR 73M

03/11/2024 Argaam Exclusive

View other reports

Saudi Chemical Holding Co. (SCHC) reported a net profit surge to SAR 237.2 million in the first nine months of 2024, from SAR 93.9 million in the year-earlier period.

Financials (M)

Item	9m 2023	9m 2024	Change‬
Revenues	3,445.99	4,613.60	33.9 %
Gross Income	456.04	620.01	36.0 %
Operating Income	198.67	355.44	78.9 %
Net Income	93.88	237.16	152.6 %
Average Shares	843.20	843.20	-
EPS (Riyals)	0.11	0.28	152.6 %

The nine-month profit growth was driven by a 34% year-on-year (YoY) increase in revenue to SAR 1.17 billion, supported by higher sales volumes and operating profits.

SCHC reported increased sales volumes despite losses from a joint venture investment, revaluation gains on derivative financial instruments linked to interest rate exposure, and higher Zakat and tax provisions.

In Q3 2024, the company reported a SAR 153.6 revenue increase, up 13% YoY on higher sales volumes.

The company’s net earnings more than doubled to SAR 73 million in Q3 2024, from SAR 35.10 million in Q3 2023, as operating profits rose on higher sales volume and lower financing costs (FCs).

Net earnings edged up 0.4% in Q3 2024, from SAR 72.71million in Q2 2024.

Meanwhile, the company’s revenue declined in the current quarter by SAR 261.4 million, or 16% quarter-on-quarter (QoQ) due to a decrease in certain sales volumes.

Current Quarter Comparison (M)

Compared With The

Item	Q3 2023	Q3 2024	Change‬
Revenues	1,200.01	1,353.61	12.8 %
Gross Income	159.41	201.80	26.6 %
Operating Income	72.05	121.34	68.4 %
Net Income	35.10	72.99	107.9 %
Average Shares	843.20	843.20	-
EPS (Riyals)	0.04	0.09	107.9 %

Item	Q2 2024	Q3 2024	Change‬
Revenues	1,615.03	1,353.61	(16.2 %)
Gross Income	204.58	201.80	(1.4 %)
Operating Income	114.84	121.34	5.7 %
Net Income	72.71	72.99	0.4 %
Average Shares	843.20	843.20	-
EPS (Riyals)	0.09	0.09	0.4 %

Shareholders’ equity, after minority interest, reached SAR 2.03 billion by Sept. 30, 2024, compared to SAR 1.75 billion in the prior-year period.

View more financial results

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
Q1 2015	678.47	(2.1 %)	139.29	(4.1 %)	93.21	(6.9 %)
Q2 2015	636.15	(2.4 %)	141.08	1.7 %	87.33	(6.7 %)
Q3 2015	489.68	(7.4 %)	85.74	(13.4 %)	41.49	(14.8 %)
Q4 2015	607.57	(0.5 %)	128.97	7.6 %	63.13	(12.4 %)
2015	2,409.77	(3.0 %)	492.99	(1.9 %)	283.07	(10.0 %)
Q1 2016	588.45	(13.3 %)	111.67	(19.8 %)	62.63	(32.8 %)
Q2 2016	617.59	(2.9 %)	114.15	(19.1 %)	60.50	(30.7 %)
Q3 2016	444.82	(9.2 %)	75.31	(12.2 %)	29.12	(29.8 %)
Q4 2016	492.21	(19.0 %)	86.44	(33.0 %)	41.73	(33.9 %)
2016	2,143.06	(11.1 %)	387.57	(21.4 %)	193.98	(31.5 %)
Q1 2017	724.68	23.2 %	118.40	6.0 %	66.40	6.0 %
Q2 2017	544.28	(11.9 %)	93.09	(18.5 %)	40.00	(33.9 %)
Q3 2017	513.16	15.4 %	83.60	11.0 %	37.06	27.3 %
Q4 2017	692.22	40.6 %	101.23	17.1 %	44.10	5.7 %
2017	2,474.34	15.5 %	396.31	2.3 %	187.55	(3.3 %)
Q1 2018	791.18	9.2 %	121.48	2.6 %	71.27	7.3 %
Q2 2018	653.78	20.1 %	93.63	0.6 %	38.79	(3.0 %)
Q3 2018	630.81	22.9 %	84.18	0.7 %	28.04	(24.3 %)
Q4 2018	872.77	26.1 %	111.15	9.8 %	45.84	4.0 %
2018	2,948.53	19.2 %	410.44	3.6 %	183.94	(1.9 %)
Q1 2019	840.16	6.2 %	125.36	3.2 %	57.43	(19.4 %)
Q2 2019	775.99	18.7 %	120.75	29.0 %	49.31	27.1 %
Q3 2019	737.05	16.8 %	113.62	35.0 %	35.53	26.7 %
Q4 2019	595.97	(31.7 %)	98.23	(11.6 %)	(17.78)	(138.8 %)
2019	2,949.17	0.0 %	457.96	11.6 %	124.49	(32.3 %)
Q1 2020	799.58	(4.8 %)	130.14	3.8 %	54.30	(5.4 %)
Q2 2020	858.72	10.7 %	125.24	3.7 %	58.17	18.0 %
Q3 2020	811.35	10.1 %	104.92	(7.7 %)	38.55	8.5 %
Q4 2020	836.51	40.4 %	73.80	(24.9 %)	(1.40)	92.1 %
2020	3,306.16	12.1 %	436.41	(4.7 %)	149.63	20.2 %
Q1 2021	969.46	21.2 %	128.94	(0.9 %)	60.82	12.0 %
Q2 2021	899.91	4.8 %	127.66	1.9 %	47.14	(19.0 %)
Q3 2021	785.26	(3.2 %)	92.03	(12.3 %)	31.64	(17.9 %)
Q4 2021	756.36	(9.6 %)	83.27	12.8 %	1.99	242.2 %
2021	3,410.98	3.2 %	431.90	(1.0 %)	141.60	(5.4 %)
Q1 2022	903.99	(6.8 %)	127.49	(1.1 %)	57.31	(5.8 %)
Q2 2022	956.68	6.3 %	113.69	(10.9 %)	39.92	(15.3 %)
Q3 2022	760.51	(3.2 %)	93.49	1.6 %	22.83	(27.8 %)
Q4 2022	1,074.69	42.1 %	152.98	83.7 %	57.35	2777.4 %
2022	3,695.87	8.4 %	487.66	12.9 %	177.41	25.3 %
Q1 2023	1,039.32	15.0 %	152.22	19.4 %	69.91	22.0 %
Q2 2023	1,206.67	26.1 %	144.85	27.4 %	56.72	42.1 %
Q3 2023	1,200.01	57.8 %	159.41	70.5 %	72.05	215.5 %
Q4 2023	1,408.86	31.1 %	211.93	38.5 %	118.67	106.9 %
2023	4,854.85	31.4 %	672.66	37.9 %	317.34	78.9 %
Q1 2024	1,644.96	58.3 %	213.63	40.3 %	119.26	70.6 %
Q2 2024	1,615.03	33.8 %	204.58	41.2 %	114.84	102.5 %
Q3 2024	1,353.61	12.8 %	201.80	26.6 %	121.34	68.4 %

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
2014	2,484.32	9.2 %	502.80	4.9 %	314.50	(0.3 %)
2015	2,409.77	(3.0 %)	492.99	(1.9 %)	283.07	(10.0 %)
2016	2,143.06	(11.1 %)	387.57	(21.4 %)	193.98	(31.5 %)
2017	2,474.34	15.5 %	396.31	2.3 %	187.55	(3.3 %)
2018	2,948.53	19.2 %	410.44	3.6 %	183.94	(1.9 %)
2019	2,949.17	0.0 %	457.96	11.6 %	124.49	(32.3 %)
2020	3,306.16	12.1 %	436.41	(4.7 %)	149.63	20.2 %
2021	3,410.98	3.2 %	431.90	(1.0 %)	141.60	(5.4 %)
2022	3,695.87	8.4 %	487.66	12.9 %	177.41	25.3 %
2023	4,854.85	31.4 %	672.66	37.9 %	317.34	78.9 %

Profit Performance (Million)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
Q1 2015	86.22	(5.2 %)	0.10	-	86.22	0.10
Q2 2015	78.06	(9.9 %)	0.09	-	78.06	0.09
Q3 2015	35.75	(9.5 %)	0.04	-	35.75	0.04
Q4 2015	50.66	(23.8 %)	0.06	-	50.66	0.06
2015	250.68	(11.6 %)	0.30	-	250.68	0.30
Q1 2016	51.52	(40.2 %)	0.06	-	51.52	0.06
Q2 2016	47.40	(39.3 %)	0.06	-	47.40	0.06
Q3 2016	18.42	(48.5 %)	0.02	-	18.42	0.02
Q4 2016	17.09	(66.3 %)	0.02	(10.34)	27.43	0.03
2016	134.43	(46.4 %)	0.16	(10.34)	144.77	0.17
Q1 2017	55.20	7.1 %	0.07	-	55.20	0.07
Q2 2017	28.54	(39.8 %)	0.03	-	28.54	0.03
Q3 2017	27.85	51.2 %	0.03	-	27.85	0.03
Q4 2017	30.57	78.9 %	0.04	-	30.57	0.04
2017	142.15	5.7 %	0.17	-	142.15	0.17
Q1 2018	56.42	2.2 %	0.07	-	56.42	0.07
Q2 2018	27.82	(2.5 %)	0.03	-	27.82	0.03
Q3 2018	13.51	(51.5 %)	0.02	-	13.51	0.02
Q4 2018	17.08	(44.1 %)	0.02	-	17.08	0.02
2018	114.82	(19.2 %)	0.14	-	114.82	0.14
Q1 2019	39.30	(30.3 %)	0.05	-	39.30	0.05
Q2 2019	30.89	11.0 %	0.04	-	30.89	0.04
Q3 2019	13.40	(0.8 %)	0.02	-	13.40	0.02
Q4 2019	(50.72)	(397.0 %)	(0.06)	-	(50.72)	(0.06)
2019	32.88	(71.4 %)	0.04	-	32.88	0.04
Q1 2020	37.97	(3.4 %)	0.05	-	37.97	0.05
Q2 2020	40.17	30.0 %	0.05	-	40.17	0.05
Q3 2020	18.85	40.7 %	0.02	-	18.85	0.02
Q4 2020	(22.96)	54.7 %	(0.03)	-	(22.96)	(0.03)
2020	74.03	125.2 %	0.09	-	74.03	0.09
Q1 2021	40.83	7.5 %	0.05	-	40.83	0.05
Q2 2021	27.27	(32.1 %)	0.03	-	27.27	0.03
Q3 2021	7.75	(58.9 %)	0.01	-	7.75	0.01
Q4 2021	(6.28)	72.7 %	(0.01)	-	(6.28)	(0.01)
2021	69.57	(6.0 %)	0.08	-	69.57	0.08
Q1 2022	32.71	(19.9 %)	0.04	-	32.71	0.04
Q2 2022	13.80	(49.4 %)	0.02	-	13.80	0.02
Q3 2022	10.33	33.2 %	0.01	-	10.33	0.01
Q4 2022	23.40	472.7 %	0.03	-	23.40	0.03
2022	80.22	15.3 %	0.10	-	80.22	0.10
Q1 2023	32.27	(1.3 %)	0.04	-	32.27	0.04
Q2 2023	26.55	92.5 %	0.03	-	26.55	0.03
Q3 2023	35.10	240.0 %	0.04	-	35.10	0.04
Q4 2023	89.01	280.4 %	0.11	-	89.01	0.11
2023	182.89	128.0 %	0.22	-	182.89	0.22
Q1 2024	91.45	183.4 %	0.11	-	91.45	0.11
Q2 2024	72.71	173.9 %	0.09	-	72.71	0.09
Q3 2024	72.99	107.9 %	0.09	-	72.99	0.09

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
2014	283.56	(5.7 %)	0.34	2.09	281.47	0.33
2015	250.68	(11.6 %)	0.30	-	250.68	0.30
2016	134.43	(46.4 %)	0.16	(10.34)	144.77	0.17
2017	142.15	5.7 %	0.17	-	142.15	0.17
2018	114.82	(19.2 %)	0.14	-	114.82	0.14
2019	32.88	(71.4 %)	0.04	-	32.88	0.04
2020	74.03	125.2 %	0.09	-	74.03	0.09
2021	69.57	(6.0 %)	0.08	-	69.57	0.08
2022	80.22	15.3 %	0.10	-	80.22	0.10
2023	182.89	128.0 %	0.22	-	182.89	0.22

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2015	20.12 %	13.27 %	11.21 %
Q2 2015	20.34 %	13.11 %	11.01 %
Q3 2015	20.12 %	13.05 %	11.04 %
Q4 2015	20.53 %	12.70 %	10.39 %
2015	20.46 %	12.63 %	10.40 %
Q1 2016	20.13 %	11.88 %	9.30 %
Q2 2016	19.13 %	10.76 %	8.05 %
Q3 2016	19.04 %	10.39 %	7.44 %
Q4 2016	18.08 %	10.13 %	6.76 %
2016	18.08 %	10.13 %	6.76 %
Q1 2017	17.30 %	9.71 %	6.51 %
Q2 2017	16.92 %	9.17 %	5.87 %
Q3 2017	16.78 %	9.17 %	6.11 %
Q4 2017	16.02 %	8.52 %	5.74 %
2017	16.02 %	8.52 %	5.74 %
Q1 2018	15.72 %	8.50 %	5.64 %
Q2 2018	15.09 %	8.20 %	5.38 %
Q3 2018	14.47 %	7.69 %	4.64 %
Q4 2018	13.92 %	7.35 %	3.89 %
2018	13.92 %	7.35 %	3.89 %
Q1 2019	13.82 %	6.89 %	3.26 %
Q2 2019	14.15 %	7.00 %	3.23 %
Q3 2019	14.60 %	7.11 %	3.12 %
Q4 2019	15.53 %	5.59 %	1.11 %
2019	15.53 %	5.59 %	1.11 %
Q1 2020	15.91 %	5.60 %	1.08 %
Q2 2020	15.62 %	5.81 %	1.36 %
Q3 2020	14.96 %	5.78 %	1.51 %
Q4 2020	13.13 %	5.93 %	2.24 %
2020	13.20 %	5.93 %	2.24 %
Q1 2021	12.45 %	5.84 %	2.21 %
Q2 2021	12.38 %	5.46 %	1.82 %
Q3 2021	12.10 %	5.31 %	1.51 %
Q4 2021	12.66 %	5.49 %	2.04 %
2021	12.66 %	5.49 %	2.04 %
Q1 2022	12.87 %	5.50 %	1.84 %
Q2 2022	12.24 %	5.20 %	1.41 %
Q3 2022	12.37 %	4.96 %	1.50 %
Q4 2022	13.19 %	6.02 %	2.17 %
2022	13.19 %	6.02 %	2.17 %
Q1 2023	13.37 %	6.12 %	2.08 %
Q2 2023	13.32 %	6.13 %	2.27 %
Q3 2023	13.48 %	6.65 %	2.60 %
Q4 2023	13.77 %	7.49 %	3.77 %
2023	13.86 %	7.49 %	3.77 %
Q1 2024	13.37 %	7.61 %	4.43 %
Q2 2024	13.45 %	8.12 %	4.91 %
Q3 2024	13.81 %	-	5.42 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2014	20.24 %	13.37 %	11.33 %
2015	20.46 %	12.63 %	10.40 %
2016	18.08 %	10.13 %	6.76 %
2017	16.02 %	8.52 %	5.74 %
2018	13.92 %	7.35 %	3.89 %
2019	15.53 %	5.59 %	1.11 %
2020	13.20 %	5.93 %	2.24 %
2021	12.66 %	5.49 %	2.04 %
2022	13.19 %	6.02 %	2.17 %
2023	13.86 %	7.49 %	3.77 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2015	20.53 %	14.51 %	12.71 %
Q2 2015	22.18 %	14.55 %	12.27 %
Q3 2015	17.51 %	9.58 %	7.30 %
Q4 2015	21.23 %	11.27 %	8.34 %
Q1 2016	18.98 %	11.55 %	8.76 %
Q2 2016	18.48 %	10.44 %	7.67 %
Q3 2016	16.93 %	7.59 %	4.14 %
Q4 2016	17.56 %	10.33 %	5.57 %
Q1 2017	16.34 %	9.97 %	7.62 %
Q2 2017	17.10 %	8.34 %	5.24 %
Q3 2017	16.29 %	7.83 %	5.43 %
Q4 2017	14.62 %	7.66 %	4.42 %
Q1 2018	15.35 %	9.78 %	7.13 %
Q2 2018	14.32 %	7.14 %	4.26 %
Q3 2018	13.34 %	5.69 %	2.14 %
Q4 2018	12.74 %	6.50 %	1.96 %
Q1 2019	14.92 %	8.00 %	4.68 %
Q2 2019	15.56 %	7.54 %	3.98 %
Q3 2019	15.42 %	6.36 %	1.82 %
Q4 2019	16.48 %	(1.29 %)	(8.51 %)
Q1 2020	16.28 %	8.17 %	4.75 %
Q2 2020	14.58 %	8.08 %	4.68 %
Q3 2020	12.93 %	6.17 %	2.32 %
Q4 2020	8.82 %	1.37 %	(2.75 %)
Q1 2021	13.30 %	7.45 %	4.21 %
Q2 2021	14.19 %	6.50 %	3.03 %
Q3 2021	11.72 %	5.51 %	0.99 %
Q4 2021	11.01 %	1.78 %	(0.83 %)
Q1 2022	14.10 %	7.61 %	3.62 %
Q2 2022	11.88 %	5.38 %	1.44 %
Q3 2022	12.29 %	4.46 %	1.36 %
Q4 2022	14.23 %	6.36 %	2.18 %
Q1 2023	14.65 %	7.76 %	3.10 %
Q2 2023	12.00 %	5.59 %	2.20 %
Q3 2023	13.28 %	7.03 %	2.92 %
Q4 2023	15.04 %	9.32 %	6.32 %
Q1 2024	12.99 %	8.06 %	5.56 %
Q2 2024	12.67 %	7.94 %	4.50 %
Q3 2024	14.91 %	-	5.39 %

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
Q1 2015	843.20	0.33	0.33	1.93
Q2 2015	843.20	0.32	0.32	1.80
Q3 2015	843.20	0.32	0.32	1.84
Q4 2015	843.20	0.30	0.30	1.90
Q1 2016	843.20	0.26	0.26	1.75
Q2 2016	843.20	0.22	0.22	1.81
Q3 2016	843.20	0.20	0.20	1.83
Q4 2016	843.20	0.16	0.17	1.74
Q1 2017	843.20	0.16	0.18	1.81
Q2 2017	843.20	0.14	0.15	1.76
Q3 2017	843.20	0.15	0.16	1.80
Q4 2017	843.20	0.17	0.17	1.76
Q1 2018	843.20	0.17	0.17	1.83
Q2 2018	843.20	0.17	0.17	1.86
Q3 2018	843.20	0.15	0.15	1.78
Q4 2018	843.20	0.14	0.14	1.81
Q1 2019	843.20	0.12	0.12	1.85
Q2 2019	843.20	0.12	0.12	1.89
Q3 2019	843.20	0.12	0.12	1.90
Q4 2019	843.20	0.04	0.04	1.84
Q1 2020	843.20	0.04	0.04	1.89
Q2 2020	843.20	0.05	0.05	1.94
Q3 2020	843.20	0.05	0.05	1.96
Q4 2020	843.20	0.09	0.09	1.93
Q1 2021	843.20	0.09	0.09	1.98
Q2 2021	843.20	0.08	0.08	1.96
Q3 2021	843.20	0.06	0.06	1.97
Q4 2021	843.20	0.08	0.08	1.92
Q1 2022	843.20	0.07	0.07	1.96
Q2 2022	843.20	0.06	0.06	1.97
Q3 2022	843.20	0.06	0.06	1.99
Q4 2022	843.20	0.10	0.10	1.97
Q1 2023	843.20	0.09	0.09	2.01
Q2 2023	843.20	0.11	0.11	2.04
Q3 2023	843.20	0.14	0.14	2.08
Q4 2023	843.20	0.22	0.22	2.14
Q1 2024	843.20	0.29	0.29	2.24
Q2 2024	843.20	0.34	0.34	2.33
Q3 2024	843.20	0.39	0.39	2.42

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2014	843.20	0.34	0.33	1.83
2015	843.20	0.30	0.30	1.90
2016	843.20	0.16	0.17	1.74
2017	843.20	0.17	0.17	1.76
2018	843.20	0.14	0.14	1.81
2019	843.20	0.04	0.04	1.84
2020	843.20	0.09	0.09	1.93
2021	843.20	0.08	0.08	1.92
2022	843.20	0.10	0.10	1.97
2023	843.20	0.22	0.22	2.14

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2015	15.68	15.79	2.68
Q2 2015	17.04	17.04	3.03
Q3 2015	14.78	14.78	2.53
Q4 2015	14.46	14.46	2.27
Q1 2016	13.72	13.72	2.00
Q2 2016	14.53	14.53	1.76
Q3 2016	11.77	11.77	1.28
Q4 2016	18.32	17.01	1.68
Q1 2017	15.42	14.35	1.40
Q2 2017	20.31	18.69	1.63
Q3 2017	17.20	15.92	1.46
Q4 2017	14.29	14.29	1.37
Q1 2018	14.60	14.60	1.36
Q2 2018	15.80	15.80	1.44
Q3 2018	16.17	16.17	1.38
Q4 2018	17.10	17.10	1.29
Q1 2019	20.97	20.97	1.31
Q2 2019	19.42	19.42	1.23
Q3 2019	21.78	21.78	1.36
Q4 2019	61.50	61.50	1.30
Q1 2020	54.91	54.91	1.09
Q2 2020	47.51	47.51	1.19
Q3 2020	60.87	60.87	1.71
Q4 2020	39.81	39.81	1.81
Q1 2021	38.99	38.99	1.79
Q2 2021	53.96	53.96	2.08
Q3 2021	65.37	65.37	2.08
Q4 2021	41.09	41.09	1.77
Q1 2022	47.55	47.55	1.77
Q2 2022	53.43	53.43	1.54
Q3 2022	50.46	50.46	1.52
Q4 2022	27.85	27.85	1.35
Q1 2023	30.65	30.65	1.45
Q2 2023	34.44	34.44	1.85
Q3 2023	32.92	32.92	2.20
Q4 2023	19.91	19.91	2.02
Q1 2024	23.89	23.89	3.06
Q2 2024	32.99	32.99	4.84
Q3 2024	29.63	29.63	4.74

Period	P/E	Adjusted P/E	Price/book
2014	12.77	12.86	2.35
2015	14.46	14.46	2.27
2016	18.32	17.01	1.68
2017	14.29	14.29	1.37
2018	17.10	17.10	1.29
2019	61.50	61.50	1.30
2020	39.81	39.81	1.81
2021	41.09	41.09	1.77
2022	27.85	27.85	1.35
2023	19.92	19.92	2.02

Business Segments (Million)

Compared With The

Period	Medicines and medical supplies	Explosives sector	Production of ammonium nitrate	Eliminations
Q1 2015	560.46	115.12	2.89	-
Q2 2015	519.48	113.30	3.37	-
Q3 2015	407.09	77.87	2.63	-
Q4 2015	495.40	108.75	3.42	-
Q1 2016	486.51	100.15	1.79	-
Q2 2016	523.71	92.30	1.58	-
Q3 2016	380.20	67.99	-	-
Q4 2016	401.59	84.23	6.39	-
Q1 2017	642.39	81.80	0.49	-
Q2 2017	461.84	80.81	1.63	-
Q3 2017	439.71	69.84	3.61	-
Q4 2017	601.78	86.92	3.52	-
Q1 2018	709.39	79.68	2.11	-
Q2 2018	593.51	58.30	1.97	-
Q3 2018	574.96	48.59	7.26	-
Q4 2018	802.01	64.80	5.96	-
Q1 2019	763.56	66.18	10.41	-
Q2 2019	710.38	61.38	4.22	-
Q3 2019	672.06	62.22	2.77	-
Q4 2019	517.16	77.92	0.89	-
Q1 2020	726.04	72.05	1.50	-
Q2 2020	795.97	59.60	3.15	-
Q3 2020	742.42	63.35	5.58	-
Q4 2020	792.06	80.38	50.75	(86.68)
Q1 2021	899.75	81.63	10.62	(22.54)
Q2 2021	832.20	67.33	19.25	(18.88)
Q3 2021	736.30	59.25	16.19	(26.48)
Q4 2021	701.59	72.71	16.86	(34.81)
Q1 2022	851.54	81.15	16.44	(45.14)
Q2 2022	904.92	63.43	11.81	(23.49)
Q3 2022	713.06	59.02	14.35	(25.92)
Q4 2022	978.19	120.57	35.03	(59.09)
Q1 2023	919.88	130.29	26.16	(37.02)
Q2 2023	1,154.27	89.57	19.83	(57.00)
Q3 2023	1,105.90	129.17	19.56	(54.63)
Q4 2023	1,293.01	156.63	28.64	(69.41)
Q1 2024	1,536.56	137.11	28.23	(56.93)
Q2 2024	1,565.90	81.59	9.13	(41.59)
Q3 2024	1,316.72	79.78	19.38	(62.27)

Period	Medicines and medical supplies	Explosives sector	Production of ammonium nitrate	Eliminations
2014	2,026.05	454.25	4.02	-
2015	1,982.43	415.03	12.31	-
2016	1,792.00	344.67	6.39	-
2017	2,145.72	319.37	9.25	-
2018	2,679.85	251.37	17.31	-
2019	2,663.16	267.71	18.30	-
2020	3,056.49	275.37	60.98	(86.68)
2021	3,169.84	280.92	62.92	(102.70)
2022	3,447.70	324.18	77.63	(153.64)
2023	4,473.07	505.66	94.19	(218.06)

Financial Ratios

	Current
Market Cap (M Riyal)	8,432.00
Enterprise Value (EV) (M)	9,595.40
Shares Outstanding ((M))	843.20
EPS ( Riyal) (TTM)	0.39
Book Value (BV) ( Riyal)	2.42
Par Value ( Riyal)	1.00
Adjusted P/E (Last12)	25.85
P/E (TTM)	25.85
Price/book	4.14
Return on Average Assets (%) (TTM)	5.9
Return on Average Equity (%) (TTM)	17.2

Saudi Chemical Co. (CHEMICAL)

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Saudi Chemical 9M 2024 profit climbs to SAR 237.2M; Q3 at SAR 73M

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2024 Q3

Financial Ratios

Share Price

Saudi Chemical Co. (CHEMICAL)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

×

Saudi Chemical 9M 2024 profit climbs to SAR 237.2M; Q3 at SAR 73M

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q3 2024

Revenue by Business Segment (Latest) 2024 Q3

Financial Ratios

Share Price

Saudi Chemical Co. (CHEMICAL)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)